Bank of New York Mellon
INBX icon

Bank of New York Mellon’s Inhibrx INBX Stock Holding History

Bank of New York Mellon’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.48M Buy
26,200
+326
+1% +$32.7K ﹤0.01% 2821
2026
Q1 		$1.74M Sell
25,874
-874
-3% -$64.8K ﹤0.01% 2886
2025
Q4 		$2.11M Sell
26,748
-23,377
-47% -$1.59M ﹤0.01% 2798
2025
Q3 		$1.69M Sell
50,125
-353
-0.7% -$8.69K ﹤0.01% 2905
2025
Q2 		$720K Sell
50,478
-2,322
-4% -$30K ﹤0.01% 3308
2025
Q1 		$739K Buy
52,800
+1,355
+3% +$18.4K ﹤0.01% 3234
2024
Q4 		$792K Buy
51,445
+25,712
+100% +$392K ﹤0.01% 3289
2024
Q3 		$403K Sell
25,733
-5,593
-18% -$78.6K ﹤0.01% 3623
2024
Q2 		$444K Buy
+31,326
New +$489K ﹤0.01% 3639

Other funds holding INBX

S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
WSL
Western Standard LLC Los Angeles, California $295M AUM 40.98% 1-Year Est. Return

Bank of New York Mellon's INBX Position: Q2 2026 in Review

Bank of New York Mellon increased its Inhibrx (INBX) stake by 1.3% in Q2 2026, buying an estimated $32.7K and bringing the position to 26,200 shares worth $2.48M. The position accounts for ﹤0.01% of the portfolio, ranked #2821.

Bank of New York Mellon first reported a position in INBX in Q2 2024 and has held it in 9 quarters since. 75 funds tracked by Wall St. Rank hold INBX as of Q2 2026.

  • Bank of New York Mellon held 26,200 shares of Inhibrx worth $2.48M as of Q2 2026.
  • Bank of New York Mellon bought 326 Inhibrx shares in Q2 2026, an estimated $32.7K.
  • Inhibrx made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #2821 holding.
  • Bank of New York Mellon first reported a position in Inhibrx in Q2 2024 and has held it in 9 quarters since.
  • 75 funds tracked by Wall St. Rank held Inhibrx as of Q2 2026.

Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.